Prior studies have shown that administration of recombinant EAP and/or its analogues are feasible in animal models and one Phase I testing in humans resulted in no serious adverse reactions, demonstrating that EAP-based therapies are feasible and that ultimately small molecule orally-available agent.....
[Detail]
According to the World Health Organization (WHO), worldwide, there are 422 million individuals with diabetes mellitus (DM). The prevalence of DM continues to grow and is projected to be the seventh leading cause of death by 2030. Supplies and treatment of DM are expensive, costing individuals, on av.....
[Detail]
ApplicationsThese10 IgG monoclonal antibodies were generated against various strains of Mycoplasma gallisepticum and recognize M. gallisepticum surface epitopes, andtheir use has been validated for ELISA, DIBA, immunoblotting, immunoperoxidaseassay and Haemagglutination Inhibition applications, and .....
[Detail]
Description of Technology Michigan State University’s invention relates to a multi-step synthesis of a 1, 5-dideoxy-1, 5-imino hexitol from a ketoaldonic acid methyl ester of a hexose sugar with protected hydroxyl groups to novel intermediates. In particular, the invention relates to processes which.....
[Detail]
| |< <- | [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] | -> >| |
